Patient Assistance Programs and Anti-Kickback Laws

Kraschel K, Curfman G. Patient Assistance Programs and Anti-Kickback Laws. JAMA. 2019 Aug 6;322(5):405-406. doi: 10.1001/jama.2019.9791. PMID: 31386116.

Posted: 13 Nov 2020

See all articles by Katherine Kraschel

Katherine Kraschel

Yale University - Solomon Center for Health Law and Policy

Gregory Curfman

American Medical Association

Date Written: 2019

Abstract

This editorial discusses patient assistance programs that help patients with their cost sharing obligations. It describes the role of pharmaceutical companies' tax-exempt donations to patient assistance foundations, the regulatory landscape in which these payments transpire, and recent findings of non-compliance.

Suggested Citation

Kraschel, Katherine and Curfman, Gregory, Patient Assistance Programs and Anti-Kickback Laws (2019). Kraschel K, Curfman G. Patient Assistance Programs and Anti-Kickback Laws. JAMA. 2019 Aug 6;322(5):405-406. doi: 10.1001/jama.2019.9791. PMID: 31386116., Available at SSRN: https://ssrn.com/abstract=3698994

Katherine Kraschel (Contact Author)

Yale University - Solomon Center for Health Law and Policy ( email )

127 Wall Street
New Haven, CT 06511
United States

Gregory Curfman

American Medical Association ( email )

330 N. Wabash Avenue
41st Floor
Chicago, IL 60611
United States
9785059696 (Phone)

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
62
PlumX Metrics